|Videos|April 9, 2013
Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives
Advertisement
Episodes in this series
In today’s healthcare and managed care environments, patients, physicians, and providers are faced with numerous challenges, including adverse drug events, disjointed patient care, the issues of poly-pharmacy, and ineffective lines of communication that impede the optimal care delivery. Various strategies, such as patient engagement, are being implemented to streamline patient care delivery in an effort to improve clinical outcomes while reducing healthcare expenditures and economic burden.
Advertisement
Related to this article
The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
In states that covered obesity-labeled GLP-1 RAs, total GLP-1 RA use rose less than obesity-labeled use alone, suggesting possible substitution.
HR 1 brings Medicaid work requirements and narrower immigrant eligibility by January 2027, and CBO projects 10 million more uninsured by 2034.
CMS ends ACA subsidies for 189,000 enrollees with duplicate Medicare, Medicaid, or CHIP coverage or listed as deceased, with a 30-day dispute window.
MedHaul’s platform streamlines nonemergency medical transportation, boosting on-time oncology visits, reducing costs, and helping patients reach critical care across underserved regions.
CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
Advertisement
Advertisement